npj Vaccines

Article	Citations
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine	258
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complement	194
Mapping global public perspectives on mRNA vaccines and therapeutics	145
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	136
The dengue-specific immune response and antibody identification with machine learning	126
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine	103
A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination	98
Rational development of a combined mRNA vaccine against COVID-19 and influenza	98
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year	98
Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection	82
Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle	79
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern	77
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity	77
Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice	76
Analyzing atomic force microscopy images of virus-like particles by expectation-maximization	71
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle	70
Assessing immunogenicity barriers of the HIV-1 envelope trimer	69
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice	68
Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines	67
Reverse development of vaccines against antimicrobial-resistant pathogens	65
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys	62
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens	61
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice	61
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses	58
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	57

Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax	57
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen	57
mRNA-LNP vaccine encoding CDV hemagglutinin confers effective protection in raccoon dogs	56
Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates	55
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens	54
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex	54
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters	50
PfRH5 vaccine; from the bench to the vial	49
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination	48
LmCen−/− based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia	48
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth	47
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark	46
IL-12 mRNA-LNP promotes dermal resident memory CD4+ T cell development	45
A field test of empathetic refutational and motivational interviewing to address vaccine hesitancy among patients	44
Antibody responses against influenza A decline with successive years of annual influenza vaccination	44
Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2	43
An open repository of COVID-19 vaccine mandate studies with a worked scoping review of quasi-experimental evidence	42
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition	41
Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus	41
Novel enzymatic DNA produced from a text file achieves comparable immune responses as plasmid vaccine	40
Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox	40
Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial	40
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins	39
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus	39
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen	38
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine	37
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	35
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome	35
Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome	35
Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques	35
Mobilizing domestic support for international vaccine solidarity – recommendations for health crisis communication	34
Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge	33
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine	33
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity	33
Structural insight into the assembly and D antigenicity of polio type 1 stabilized virus-like particles	33
Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy	33
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques	33
Dithranol as novel co-adjuvant for non-invasive dermal vaccination	32
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity	32
Vaccination of cattle with the Babesia bovis sexual-stage protein HAP2 abrogates parasite transmission by Rhipicephalus microplus ticks	32
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9	32
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers	31
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets	31
Evaluation of high-throughput sequencing for replacing the conventional adventitious virus detection assays used for biologics	31
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis	30
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery	30
Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines	30
Assessing the impact of mRNA vaccination in chronic inflammatory murine model	30
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection	29
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2	29

Urgency and necessity of Epstein-Barr virus prophylactic vaccines	29
Replication in human cells supersedes serum antigenic match for the in vivo efficacy of an A/H1N1pdm09 LAIV virus	29
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression	29
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection	29
Strep A: challenges, opportunities, vaccine-based solutions, and economics	28
mRNA vaccines induce rapid antibody responses in mice	28
Optimal deployment of limited vaccine supplies to control mpox outbreaks	28
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges	28
Cancer vaccines and RNA therapeutics: exploring the impact of microRNAs	27
Effectiveness of “naturalness” value-based narrative intervention on vaccination acceptance in two randomized controlled trials	26
C5aR+ dendritic cells fine-tune the Peyer’s patch microenvironment to induce antigen-specific CD8+ T cells	26
A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice	26
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy	26
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein	26
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines	26
Immune checkpoint-engineered virus-like particles induce antigen-specific immune tolerance and protect against food allergy	26
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children	25
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58	25
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children	25
Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior	25
Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization	25
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform	25
A broadly protective vaccine against cutaneous human papillomaviruses	25
Continuing development of vaccines and monoclonal antibodies against Zika virus	25
Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany	25
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine	25
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation	24
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants	24
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans	24
Analyzing immune responses to varied mRNA and protein vaccine sequences	24
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity	24
The Streptococcus pyogenes vaccine landscape	24
Modulation of oral vaccine efficacy by the gut microbiota	24
Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopes	24
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccines	24
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary	23
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model	23
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19	23
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccine	23
Toxoplasmosis vaccines: what we have and where to go?	23
Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice	22
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice	22
Chimeric hemagglutinin and M2 mRNA vaccine for broad influenza subtype protection	22
Cocktail vaccine induces immunoprotection and modulates the fecal microbiota in dogs against Echinococcus granulosus infection	22
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine	22
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine	22
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity	22
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales	21
Development of in vitro airway epithelial model to assess immune response and safety of mucosal adjuvants	21
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns	21
Autogenous vaccines: an alternative approach to disease control in poultry	21
Accelerating the manufacturing of HIV Env protein vaccines for early phase clinical evaluation	21
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response	21
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection	21
Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies	21
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection	21
Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma	21
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness	21
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens	20
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection	20
Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis	20
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections	20
Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO)	20
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens	20
A highly immunogenic UVC inactivated Sabin based polio vaccine	20
Establishing an immune correlate of protection for Nipah virus in nonhuman primates	20
Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus	20
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development	20
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial	20
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy	20
Development of pre-pandemic influenza candidate vaccine viruses for use in vaccine manufacturing	19
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population	19
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants	19
NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae	19
The scientific journey of a novel adjuvant (AS37) from bench to bedside	19
Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge	19
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians	19
An HLAII-targeted DNA vaccine against influenza H7N9 protected mice and ferrets from a virus challenge	19
From promise to pitfalls: immunological lessons from dengue vaccines and their implications	19
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial	19

Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG	19
Genetic ancestry and population structure of vaccinia virus	19
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles	19
Transfer of breast milk IgA to infants after oral bivalent norovirus vaccination of post-partum women	19
Next-generation mRNA vaccines eliciting robust protection against multidrug-resistant Enterobacteriaceae	19
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	19
Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates	19
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons	19
B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs	19
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination	18
Is new dengue vaccine efficacy data a relief or cause for concern?	18
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China	18
Progress with COVID vaccine development and implementation	18
Publisher Correction: AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development	18
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques	18
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein	18
Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza viruses	18
Precocious Eimeria magna transgenically expressing RHDV P2 subdomain induces immune responses in rabbits	18
Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and age	18
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses	18
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2	18
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus	18
A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions	18
Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial	18
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization	17
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort	17
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles	17
Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection	17
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging	17
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice	17
Author Correction: Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests	17
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination	17
The full health, economic, and social benefits of prospective Strep A vaccination	17
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model	17
Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness	17
Spillover between influenza and COVID-19 vaccination behaviors across pandemic phases and implications for general vaccine hesitancy	16
Human naïve B cells show evidence of anergy and clonal redemption following vaccination	16
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France	16
Filovirus vaccines as a response paradigm for emerging infectious diseases	16
Divergent B-cell repertoire remodelling by mRNA, DNA and live attenuated vaccines in fish	16
Modular assembly and immunological evaluation of a promising bioconjugate nanovaccine against Klebsiella pneumoniae O2 serotype	16
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system	16
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine	16
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development	16
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza	16
Mycobacterium tuberculosis bacteriology and immunity necessitate a multi-pronged immune strategy for vaccination	16
Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice	16
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates	16
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability	16
A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine	16
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines	15
Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza	15
Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers	15
Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection	15
Identification and efficacy assessment of novel immunoprotective antigens from Mycoplasma synoviae for vaccine development	15
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients	15
A centralised immunogen approach to develop a more broadly protective modified live porcine reproductive and respiratory syndrome virus 1 vaccine candidate	15
Author Correction: The dengue-specific immune response and antibody identification with machine learning	15
Retraction Note: Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19	15
Evaluation of the effectiveness of social mobilization for vaccination among healthcare and non-healthcare workers in emergency situations	15
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice	15
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease	15
Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children	15
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans	15
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults	15
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine	15
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant	15
Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza viruses	14
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice	14
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2	14
Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model	14
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	14
The immunological interplay between vaccination and the intestinal microbiota	14
Optimization of an alum-anchored clinical HIV vaccine candidate	14
A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection	14
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice	14
Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines	14
Systematic review of evidence on feasibility of administering intranasal live attenuated influenza vaccine at home	14
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA	14
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination	14
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques	14
Identifying vaccine-hesitant subgroups in the Western Pacific using latent class analysis	14
Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals	14
Level of antibody to hepatitis B surface antigen declined below 10 mIU/ml is still protective	13
Sterile protection against relapsing malaria with a single-shot vaccine	13
Author Correction: Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology	13
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum	13
Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention	13
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality	13
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates	13
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts	13
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame	13
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly	13
Prior human endemic coronavirus exposure does not affect humoral responses to SARS-CoV-2 protein vaccines	13
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	13